(Q54287772)

English

Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia

scientific article published on October 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia (English)

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

molecular medicine

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

author name string

E. Abraham

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759494

17 November 2022

A. Robinson

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759494

17 November 2022

language of work or name

0 references

publication date

1 October 1991

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

number of pages

8

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:0264410X9190293F?httpAccept=text/xml

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

https://api.elsevier.com/content/article/PII:0264410X9190293F?httpAccept=text/plain

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

9

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

757-764

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

10

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

Epidemiology of trauma deaths

1

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

The immune consequences of trauma

2

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Cardiopulmonary Parameters and Prognosis after Severe Multiple Trauma

4

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Causes of death after blunt trauma.

5

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Correlation of immunologic and nutritional status with infectious complications after major abdominal trauma

6

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients

7

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Preventing lower airway colonization and infection in mechanically ventilated patients.

8

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care

10

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Nosocomial infections in intensive care wards: a multicenter prospective study.

12

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis

15

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation

16

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Hemorrhage in mice produces alterations in B cell repertoires

18

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Hemorrhage in mice produces alterations in intestinal B cell repertoires

19

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Hemorrhage in mice produces alterations in pulmonary B cell repertoires

20

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Immunoglobulin A: strategic defense initiative at the mucosal surface

21

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Protection against enteric bacterial infection by secretory IgA antibodies

22

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA.

23

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A

24

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

The common mucosal immune system and current strategies for induction of immune responses in external secretions

27

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Influenza-specific antibody-secreting cells and B cell memory in the murine lung after immunization with wild-type, cold-adapted variant and inactivated influenza viruses.

30

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa

31

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice

32

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Purification and characterization of intraparenchymal lung lymphocytes

34

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Inverse correlation between the utilization of an idiotype in specific immune responses and its representation in pre-immune "natural" antibodies.

35

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells

36

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview.

38

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit

42

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Cholera toxin promotes B cell isotype differentiation

43

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response

45

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus

46

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Effects of hemorrhage on inflammatory response

47

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans

52

1 reference

10.1016/0264-410X(91)90293-F

https://api.crossref.org/works/10.1016/0264-410X(91)90293-F

17 November 2022

Identifiers

10.1016/0264-410X(91)90293-F

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/1759494

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54287772&oldid=1775334787"